Sylvia F. Boj
foundation Hubrecht Organoid Technology
Sylvia Boj received her PhD from the University of Barcelona and trained as postdoctoral EMBO fellow in the laboratory of Prof. Hans Clevers, where she established an in vitro organoid model for human pancreatic cancers.
In 2013, she joined HUB as one of the founding scientist and worked as a group leader for Cystic Fibrosis and Cancer Organoid programs. In 2016, she was appointed Scientific Director at HUB. Since 2020, she holds the position of Chief Scientific Officer.
Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Sylvia F. Boj1,
Annelotte M. Vonk2,
Marvin Statia1,
Jinyi Su1,
Johanna F. Dekkers3,
Robert R. G. Vries1,
Jeffrey M. Beekman2,
Hans Clevers1,4
1, Foundation Hubrecht Organoid Technology,
2Department of Pediatric Pulmonology, Regenerative Medicine Centre Utrecht, Wilhelmina Children's Hospital, University Medical Centre Utrecht,
3Department of Stem Cells and Cancer, Walter and Eliza Hall Institute of Medical Research,
4Hubrecht Institute for Developmental Biology and Stem Cell Research, University Medical Centre Utrecht
Medium-Throughput Drug- and Radiotherapy Screening Assay using Patient-Derived Organoids
Marrit Putker*,1,
Rosemary Millen*,2,
René Overmeer*,3,
Else Driehuis2,4,
Maurice M. J. M. Zandvliet5,
Hans Clevers2,
Sylvia F. Boj3,
Qi-Xiang Li6
1, Crown Bioscience Netherlands B.V.,
2Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht,
3, Hubrecht Organoid Technology (HUB),
4Pathology dept, University Medical Center Utrecht,
5Department of Clinical Sciences - Companion Animals, Faculty of Veterinary Medicine, Utrecht University,
6, Crown Bioscience Inc.
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。